These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 20633587)

  • 1. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
    Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
    Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide.
    Austen BM; Paleologou KE; Ali SA; Qureshi MM; Allsop D; El-Agnaf OM
    Biochemistry; 2008 Feb; 47(7):1984-92. PubMed ID: 18189413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Compensatory function of transthyretin in Alzheimer's disease].
    Shwartsman AL; Sarantseva SV
    Tsitologiia; 2011; 53(10):772-7. PubMed ID: 22232933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity.
    Saraiva AM; Cardoso I; Saraiva MJ; Tauer K; Pereira MC; Coelho MA; Möhwald H; Brezesinski G
    Macromol Biosci; 2010 Oct; 10(10):1152-63. PubMed ID: 20480510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.
    Schuster D; Rajendran A; Hui SW; Nicotera T; Srikrishnan T; Kruzel ML
    Neuropeptides; 2005 Aug; 39(4):419-26. PubMed ID: 15890402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retro-enantio N-methylated peptides as beta-amyloid aggregation inhibitors.
    Grillo-Bosch D; Carulla N; Cruz M; Sánchez L; Pujol-Pina R; Madurga S; Rabanal F; Giralt E
    ChemMedChem; 2009 Sep; 4(9):1488-94. PubMed ID: 19591190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro.
    Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.
    Han M; Liu Y; Tan Q; Zhang B; Wang W; Liu J; Zhang XJ; Wang YY; Zhang JM
    Eur J Pharmacol; 2011 Apr; 657(1-3):104-10. PubMed ID: 21316359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-modified protein microspheres capture amyloid-β and inhibit its aggregation and toxicity.
    Richman M; Wilk S; Skirtenko N; Perelman A; Rahimipour S
    Chemistry; 2011 Sep; 17(40):11171-7. PubMed ID: 21887833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Branched KLVFF tetramers strongly potentiate inhibition of beta-amyloid aggregation.
    Chafekar SM; Malda H; Merkx M; Meijer EW; Viertl D; Lashuel HA; Baas F; Scheper W
    Chembiochem; 2007 Oct; 8(15):1857-64. PubMed ID: 17763487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
    De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
    FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
    Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
    Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity.
    Pallitto MM; Ghanta J; Heinzelman P; Kiessling LL; Murphy RM
    Biochemistry; 1999 Mar; 38(12):3570-8. PubMed ID: 10090743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light-controlled toxicity of engineered amyloid β-peptides.
    Hoppmann C; Barucker C; Lorenz D; Multhaup G; Beyermann M
    Chembiochem; 2012 Dec; 13(18):2657-60. PubMed ID: 23161824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-n oligomers as therapeutic targets of Alzheimer's disease.
    Ono K; Yamada M
    J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β: the seeds of darkness.
    Fodero-Tavoletti MT; Villemagne VL; Rowe CC; Masters CL; Barnham KJ; Cappai R
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1247-51. PubMed ID: 21601003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-peptide conjugates for binding beta-amyloid plaques of Alzheimer's disease.
    Zhang G; Leibowitz MJ; Sinko PJ; Stein S
    Bioconjug Chem; 2003; 14(1):86-92. PubMed ID: 12526697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein.
    Miyamae Y; Kurisu M; Murakami K; Han J; Isoda H; Irie K; Shigemori H
    Bioorg Med Chem; 2012 Oct; 20(19):5844-9. PubMed ID: 22921742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.